Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trubliss is a leading research and development company specializing in medicinal cannabis and cannabidiol (CBD) formulations. The company is dedicated to bridging the gap between traditional medicine and natural wellness by providing high-quality, standardized, and pharmaceutical-grade CBD products. Its product portfolio includes pain relief oils, gels, roll-ons, tinctures, cough syrups, and appetite stimulants designed to alleviate musculoskeletal pain, neuropathic discomfort, anxiety, and inflammation. Trubliss operates internationally with key divisions in the United Kingdom and Kenya, collaborating with medical professionals to promote healthcare literacy and safe, controlled therapeutic cannabis use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trubliss International.